https://medicaex.com/prnewswire/lunit-secures-150-million-in-capital-increase/
Lunit Secures $150 Million in Capital Increase - MedicaEx.com
Nov 16, 2023 - Fund fully paid-in as of November 9, achieving over 100% shareholder participation
capital increaselunitmillion
https://biopharmaapac.com/news/76/7286/lunit-submits-fda-510k-for-ai-driven-five-year-breast-cancer-risk-prediction-model.html
Lunit Submits FDA 510k For AI Driven Five Year Breast Cancer Risk Prediction Model
Lunit Submits FDA 510k For AI Driven Five Year Breast Cancer Risk Prediction Model
breast cancer riskfor ailunitfdadriven
https://aithority.com/machine-learning/lunit-to-supply-ai-platform-to-australias-breastscreen-nsw-machine-reading-project/
Lunit to Supply AI Platform to Australia's BreastScreen NSW Machine Reading Project
Nov 16, 2022 - Lunit, medical AI provider serving over 1,000 sites around the world, announced that it has signed a contract to supply its AI solution
ai platformbreastscreen nswlunitsupplyaustralia
https://www.toscanamedianews.it/tag/festa-de-lunit
Festa De Lunit Qui News toscanamedia
festadelunitquinews
https://www.laboratorynetwork.com/doc/lunit-labcorp-to-advance-ai-powered-digital-pathology-research-0001
11.25.25 -- Lunit & Labcorp To Advance AI-Powered Digital Pathology Research
11/25/25 Laboratory Network Newsletter
ai powereddigital pathologylunitlabcorpadvance
https://www.medicaldevice-network.com/news/lunit-fda-breast/
Lunit seeks FDA clearance for breast cancer risk prediction model
Dec 9, 2025 - Lunit has announced the submission of a 510(k) premarket notification seeking clearance from the US FDA for its breast cancer risk prediction model.
breast cancer riskfda clearancelunitseeksprediction
https://healthairegister.com/pathology/products/lunit-scope-pd-l1
Lunit SCOPE PD-L1 - Lunit
Lunit SCOPE PD-L1 by Lunit - Advanced healthcare AI solution.
lunitscopepd
https://theimagingwire.com/2025/09/03/lunit-is-ramping-up-its-position-in-breast-cancer-risk/
Lunit Acquires Prognosia Breast Cancer Risk AI - The Imaging Wire
Sep 4, 2025 - Lunit is ramping up its position in breast cancer risk prediction by acquiring Prognosia, the developer of a risk prediction algorithm.
breast cancer risklunitaiimagingwire
https://www.biospace.com/lunit-expands-reach-of-its-ai-powered-chest-screening-solution-to-global-military-health-institutions
Lunit Expands Reach of its AI-Powered Chest Screening Solution to Global Military Health...
Nov 10, 2023 - Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has announced the successful supply of its AI-powered chest...
ai poweredmilitary healthlunitexpandsreach
https://aimonstr.com/tool/lunit-io-en
Lunit - AIMonstr
Lunit AI leverages advanced artificial intelligence to enhance cancer detection and treatment, backed by strong research and global adoption across...
lunitaimonstr
https://mercomcapital.com/tag/lunit/
Lunit Archives - Mercom Capital Group
mercom capital grouplunitarchives
https://www.marketscreener.com/news/lunit-presents-six-ai-studies-at-aacr-2026-highlighting-advances-in-precision-oncology-and-real-worl-ce7e50d3da8bf122
Lunit Presents Six AI Studies At AACR 2026 Highlighting Advances in Precision Oncology and...
Apr 17, 2026 - Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover spatial features of the tumor...
ai studiesprecision oncologylunitpresentssix
https://www.ucwe.com/tag/lunit/
lunit - The UCW Newswire : Global Financial, Business and Tech News
business and techlunitucwnewswireglobal